Liver Neoplasms, Experimental
"Liver Neoplasms, Experimental" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Experimentally induced tumors of the LIVER.
Descriptor ID |
D008114
|
MeSH Number(s) |
C04.588.274.623.460 C04.619.540 C06.301.623.460 C06.552.697.580 E05.598.500.496.750
|
Concept/Terms |
Liver Neoplasms, Experimental- Liver Neoplasms, Experimental
- Experimental Liver Neoplasm
- Liver Neoplasm, Experimental
- Neoplasms, Experimental Liver
- Experimental Liver Neoplasms
Experimental Hepatoma- Experimental Hepatoma
- Hepatoma, Experimental
- Hepatomas, Experimental
- Experimental Hepatomas
|
Below are MeSH descriptors whose meaning is more general than "Liver Neoplasms, Experimental".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Site [C04.588]
- Digestive System Neoplasms [C04.588.274]
- Liver Neoplasms [C04.588.274.623]
- Liver Neoplasms, Experimental [C04.588.274.623.460]
- Neoplasms, Experimental [C04.619]
- Liver Neoplasms, Experimental [C04.619.540]
- Digestive System Diseases [C06]
- Digestive System Neoplasms [C06.301]
- Liver Neoplasms [C06.301.623]
- Liver Neoplasms, Experimental [C06.301.623.460]
- Liver Diseases [C06.552]
- Liver Neoplasms [C06.552.697]
- Liver Neoplasms, Experimental [C06.552.697.580]
- Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
- Investigative Techniques [E05]
- Models, Animal [E05.598]
- Disease Models, Animal [E05.598.500]
- Neoplasms, Experimental [E05.598.500.496]
- Liver Neoplasms, Experimental [E05.598.500.496.750]
Below are MeSH descriptors whose meaning is more specific than "Liver Neoplasms, Experimental".
This graph shows the total number of publications written about "Liver Neoplasms, Experimental" by people in this website by year, and whether "Liver Neoplasms, Experimental" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2012 | 0 | 1 | 1 |
2015 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
2017 | 3 | 3 | 6 |
2018 | 2 | 0 | 2 |
2019 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Liver Neoplasms, Experimental" by people in Profiles.
-
Characterization of HCC Mouse Models: Towards an Etiology-Oriented Subtyping Approach. Mol Cancer Res. 2019 07; 17(7):1493-1502.
-
Sirtuin2 enhances the tumoricidal function of liver natural killer cells in a mouse hepatocellular carcinoma model. Cancer Immunol Immunother. 2019 Jun; 68(6):961-971.
-
Natural Killer Cell-Derived Interferon-Gamma Promotes Hepatocellular Carcinoma Through the Epithelial Cell Adhesion Molecule-Epithelial-to-Mesenchymal Transition Axis in Hepatitis B Virus Transgenic Mice. Hepatology. 2019 04; 69(4):1735-1750.
-
Vacuolar Protein Sorting 33B Is a Tumor Suppressor in Hepatocarcinogenesis. Hepatology. 2018 12; 68(6):2239-2253.
-
One-step preparation of nano-in-micro poly(vinyl alcohol) embolic microspheres and used for dual-modal T1/T2-weighted magnetic resonance imaging. Nanomedicine. 2018 11; 14(8):2551-2561.
-
Prospero-related homeobox 1 drives angiogenesis of hepatocellular carcinoma through selectively activating interleukin-8 expression. Hepatology. 2017 12; 66(6):1894-1909.
-
Radiation improves antitumor effect of immune checkpoint inhibitor in murine hepatocellular carcinoma model. Oncotarget. 2017 Jun 20; 8(25):41242-41255.
-
Chronic Alcohol Consumption Promotes Diethylnitrosamine-Induced Hepatocarcinogenesis via Immune Disturbances. Sci Rep. 2017 05 31; 7(1):2567.
-
Phase I and Preliminary Phase II Study of TRC105 in Combination with Sorafenib in Hepatocellular Carcinoma. Clin Cancer Res. 2017 Aug 15; 23(16):4633-4641.
-
Cell cycle-dependent degradation of the methyltransferase SETD3 attenuates cell proliferation and liver tumorigenesis. J Biol Chem. 2017 06 02; 292(22):9022-9033.